[HTML][HTML] Re-irradiation for head and neck cancer: cumulative dose to organs at risk and late side effects

A Embring, E Onjukka, C Mercke, I Lax, A Berglund… - Cancers, 2021 - mdpi.com
Simple Summary Local recurrences of head and neck cancer are unfortunately common and
can be difficult to treat. The treatment is challenging, partly due to the location, with several …

Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects.

A Embring, E Onjukka, C Mercke, I Lax, A Berglund… - Cancers, 2021 - europepmc.org
Re-irradiation in head and neck cancer is challenging, and cumulative dose constraints and
dose/volume data are scarce. In this study, we present dose/volume data for patients re …

Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects

A Embring, E Onjukka, C Mercke, I Lax… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Re-irradiation in head and neck cancer is challenging, and cumulative dose constraints and
dose/volume data are scarce. In this study, we present dose/volume data for patients re …

Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects.

A Embring, E Onjukka, C Mercke, I Lax… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Local recurrences of head and neck cancer are unfortunately
common and can be difficult to treat. The treatment is challenging, partly due to the location …

Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects

A Embring, E Onjukka, C Mercke, I Lax, A Berglund… - …, 2021 - search.proquest.com
Re-irradiation in head and neck cancer is challenging, and cumulative dose constraints and
dose/volume data are scarce. In this study, we present dose/volume data for patients re …

[HTML][HTML] Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects

A Embring, E Onjukka, C Mercke, I Lax, A Berglund… - Cancers, 2021 - ncbi.nlm.nih.gov
Re-irradiation in head and neck cancer is challenging, and cumulative dose constraints and
dose/volume data are scarce. In this study, we present dose/volume data for patients re …

Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects

A Embring, E Onjukka, C Mercke, I Lax, A Berglund… - Cancers, 2021 - cir.nii.ac.jp
抄録< jats: p> Re-irradiation in head and neck cancer is challenging, and cumulative dose
constraints and dose/volume data are scarce. In this study, we present dose/volume data for …